Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats

This research characterized vitamin k2 ameliorates experimental autoimmune encephalomyelitis in lewis rats, revealing immune dysregulation mechanisms in MS. Patient cohorts and clinical data were systematically analyzed to identify disease associations. Results identified dysregulation of immune tolerance as a key disease mechanism. Specific immune pathways drive neuroinflammatory damage in the brain and spinal cord. These findings have direct clinical relevance for MS patient management and outcomes. The work advances understanding of MS biology and supports development of improved therapies.